Glial Cells as Key Regulators in Neuroinflammatory Mechanisms Associated with Multiple Sclerosis.
Styliani TheophanousIrene SargiannidouKleopas A KleopaPublished in: International journal of molecular sciences (2024)
Even though several highly effective treatments have been developed for multiple sclerosis (MS), the underlying pathological mechanisms and drivers of the disease have not been fully elucidated. In recent years, there has been a growing interest in studying neuroinflammation in the context of glial cell involvement as there is increasing evidence of their central role in disease progression. Although glial cell communication and proper function underlies brain homeostasis and maintenance, their multiple effects in an MS brain remain complex and controversial. In this review, we aim to provide an overview of the contribution of glial cells, oligodendrocytes, astrocytes, and microglia in the pathology of MS during both the activation and orchestration of inflammatory mechanisms, as well as of their synergistic effects during the repair and restoration of function. Additionally, we discuss how the understanding of glial cell involvement in MS may provide new therapeutic targets either to limit disease progression or to facilitate repair.
Keyphrases
- multiple sclerosis
- white matter
- neuropathic pain
- mass spectrometry
- single cell
- induced apoptosis
- ms ms
- cell therapy
- cell cycle arrest
- traumatic brain injury
- oxidative stress
- spinal cord injury
- spinal cord
- inflammatory response
- resting state
- cell death
- cell proliferation
- signaling pathway
- cognitive impairment
- mesenchymal stem cells
- lipopolysaccharide induced
- lps induced
- cancer therapy